While multiple studies have also found that semaglutide reduces the risk of death
New research suggests the anti-obesity drug Ozempic could slow down ageing.
Multiple studies have also found semaglutide reduces the risk of death in people who are obese and have heart disease without diabetes.
Participants who took the drug died at a lower rate from all causes - in a study of over 17 thousand over 45s.

Member States Responsible For Suspending EU Trade Agreement With Israel - Von Der Leyen
Night Rates Energy Increases Set To Impact EV Owners
Debate Over Banning Of Hare Coursing Continues As Vote To Take Place Next Week
Tech Billionaire's Conference Cancelled By Powerscourt Hotel
Gardaí Appeal After Firearm Injures Man In Clondalkin
New Rules Will Allow You To Speak To A Human When Purchasing Over The Phone
Ursula Von Der Leyen Meeting Taoiseach And Cabinet This Morning For EU Presidency
Inquest Into Death Of Schoolboy Noah Donohue Adjourned